Americans look to Canada for lower drug prices, but are they getting the full picture?: Nigel Rawson and John Adams in The Hill
This article originally appeared in The Hill. The full article can be read here. By Nigel Rawson and John Adams, ...
Tag: drug policy
Waiting for new drugs for rare disorders in Canada, part 5 – Patented Medicine Prices Review Board: Nigel Rawson and John Adams for Inside Policy
This article is the fifth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada, part 4 – government drug plan listing: Nigel Rawson and John Adams for Inside Policy
This article is the fourth part of an 8-part series from the authors. The series, Waiting for new drugs for rare ...
Waiting for new drugs for rare disorders in Canada – part 3, price negotiation: Nigel Rawson and John Adams for Inside Policy
This article is the third part of an 8-part series from the authors. The series, Waiting for new drugs for ...
Waiting for new drugs for rare disorders in Canada – part 2, health technology assessment: Nigel Rawson and John Adams for Inside Policy
This article is the second part of an 8-part series from the authors. The series, Waiting for new drugs for ...
-
Time for an intervention – an urgent call to end “gender-affirming” treatments for children: J. Edward Les for Inside Policy
-
The Governor General deserves better, but we deserve impartiality: Philippe Lagassé for Inside Policy
-
The Lamentable Decline of Canada’s Reputation as a Dependable and Globally Respected Nation: Peter Menzies in the Epoch Times
-
Conservatives can reject destructive left-wing policies and still take climate change seriously: Brian Lee Crowley in the National Post
-
Success assured? Appraising the Canadian-led Enhanced Forward Presence battlegroup in Latvia
